Company Filing History:
2 out of 1,271 
1 out of 8,373 
1 out of 924 
Years Active: 2017-2022
Title: Matthew J Haney: Innovator in Biological Agent Delivery Systems
Introduction
Matthew J Haney is a prominent inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of biological agent delivery systems, holding a total of 3 patents. His work focuses on innovative methods for delivering biological agents to cells, which has important implications for medical treatments.
Latest Patents
One of Haney's latest patents is titled "Biological agent-exosome compositions and uses thereof." This invention relates to compositions that comprise exosomes and biological agents, along with methods for using these compositions to deliver biological agents to cells and subjects. Another notable patent is "Synthetically functionalized living cells for targeted drug delivery." This patent describes uniform, functional polymer patches that can be attached to a fraction of the surface area of living individual cells. These surface-modified cells have the capability to cross the blood-brain barrier while remaining viable after the attachment of the functional patch. The patch can carry various functional payloads, including drugs, and may consist of one or more polyelectrolyte multilayers (PEMs).
Career Highlights
Matthew J Haney has worked at prestigious institutions, including the University of North Carolina at Chapel Hill and the Massachusetts Institute of Technology. His experience at these institutions has allowed him to develop and refine his innovative ideas in the field of biological sciences.
Collaborations
Throughout his career, Haney has collaborated with notable colleagues, including Elena V Batrakova and Alexander Victorovich Kabanov. These collaborations have further enhanced his research and contributions to the field.
Conclusion
Matthew J Haney is a distinguished inventor whose work in biological agent delivery systems is paving the way for advancements in medical treatments. His innovative patents and collaborations reflect his commitment to improving healthcare through technology.